Main Menu

Translational Oncogenomics Team

Dr Marco Gerlinger's team investigates how cancer evolution and plasticity lead to resistance to cancer drugs and immunotherapies, with the aim of designing better treatments that prevent drug resistance.

Team leader

Dr Marco Gerlinger

Dr Marco Gerlinger

Honorary Appointment

Dr Marco Gerlinger developed new tools to detect and track the evolution of cancer cells and of their microenvironment and better therapies which prevent the evolution of drug resistance. He holds an Honorary Consultant Medical Oncologist position at The Royal Marsden NHS Foundation Trust, where he treats patients with gastro-intestinal cancers. Based on the research in his lab, he performed clinical trials of novel immunotherapies that aimed to leverage the immune system to attack cancer cells. Dr Gerlinger left the ICR on January 2022.

ORCID 0000-0003-2719-299X

Team members

Dr Marta Buzzetti

Honorary Appointment

Camilla Cucinotta

Honorary Appointment

Dr Hazel Lote

+44 20 7153 5427

Dr Neil McCafferty

Honorary Appointment

Alice Newey

PhD Student

Maria Semiannikova

PhD Student +44 20 7153 5129

Renske van Boxtel

BSc Student

Katharina von Loga

Honorary Appointment +44 20 3437 7524

Dr Andrew Woolston

Senior Bioinformatician